Almost One-Third Of Medications Cleared By FDA Pose Safety Risks Identified Only After Approval, Study Finds.

reports a study published in the Journal of the American Medical Association suggests that “almost a third of drugs cleared by the Food and Drug Administration pose safety risks that are identified only after their approval.” Researchers “reviewed 222 products approved between 2001 and 2010 and followed them through February of this year.” They found that for 32% of the medications evaluated, “the FDA took some kind of action to deal with safety issues that emerged after approval.” The median time for the FDA to either withdraw the drug or issue a boxed warning or safety communication was 4.2 years after the drug was approved. http://khn.org/news/1-in-3-recent-fda-drug-approvals-followed-by-major-safety-actions/